Inserm, U1110, Strasbourg, France.
J Virol. 2013 Sep;87(18):10405-10. doi: 10.1128/JVI.01691-13. Epub 2013 Jul 17.
The relevance of claudin-6 and claudin-9 in hepatitis C virus (HCV) entry remains elusive. We produced claudin-6- or claudin-9-specific monoclonal antibodies that inhibit HCV entry into nonhepatic cells expressing exogenous claudin-6 or claudin-9. These antibodies had no effect on HCV infection of hepatoma cells or primary hepatocytes. Thus, although claudin-6 and claudin-9 can serve as entry factors in cell lines, HCV infection into human hepatocytes is not dependent on claudin-6 and claudin-9.
Claudin-6 和 claudin-9 在丙型肝炎病毒 (HCV) 进入细胞中的相关性仍不清楚。我们制备了 claudin-6 或 claudin-9 特异性单克隆抗体,该抗体可抑制表达外源性 claudin-6 或 claudin-9 的非肝细胞系中的 HCV 进入。这些抗体对肝癌细胞或原代肝细胞中的 HCV 感染没有影响。因此,虽然 claudin-6 和 claudin-9 可作为细胞系中的进入因子,但 HCV 感染人肝细胞并不依赖于 claudin-6 和 claudin-9。